Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
Environ Health Perspect. Feb 2003; 111(2): 155–159.
PMCID: PMC1241343
Research Article

Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan.

Abstract

There is evidence indicating that ingestion of arsenic may predispose the development of diabetes mellitus in arsenic-endemic areas in Taiwan. However, the prevalence of diabetes and related vascular diseases in the entire southwestern arseniasis-endemic and nonendemic areas remains to be elucidated. We used the National Health Insurance Database for 1999-2000 to derive the prevalence of non-insulin-dependent diabetes and related vascular diseases by age and sex among residents in southwestern arseniasis-endemic and nonendemic areas in Taiwan. The study included 66,667 residents living in endemic areas and 639,667 in nonendemic areas, all greater than or equal to 25 years of age. The status of diabetes and vascular diseases was ascertained through disease diagnosis and treatment prescription included in the reimbursement claims of clinics and hospitals. The prevalence of non-insulin-dependent diabetes, age- and gender-adjusted to the general population in Taiwan, was 7.5% (95% confidence interval, 7.4-7.7%) in the arseniasis-endemic areas and 3.5% (3.5-3.6%) in the nonendemic areas. Among both diabetics and nondiabetics, higher prevalence of microvascular and macrovascular diseases was observed in arseniasis-endemic than in the nonendemic areas. Age- and gender-adjusted prevalence of microvascular disease in endemic and nonendemic areas was 20.0% and 6.0%, respectively, for diabetics, and 8.6% and 1.0%, respectively, for nondiabetics. The corresponding prevalence of macrovascular disease was 25.3% and 13.7% for diabetics, and 12.3% and 5.5% for nondiabetics. Arsenic has been suggested to increase the risk of non-insulin-dependent diabetes mellitus and its related micro- and macrovascular diseases.

Full Text

The Full Text of this article is available as a PDF (143K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Brouwer OF, Onkenhout W, Edelbroek PM, de Kom JF, de Wolff FA, Peters AC. Increased neurotoxicity of arsenic in methylenetetrahydrofolate reductase deficiency. Clin Neurol Neurosurg. 1992;94(4):307–310. [PubMed]
  • Chang WC, Chen SH, Wu HL, Shi GY, Murota S, Morita I. Cytoprotective effect of reduced glutathione in arsenical-induced endothelial cell injury. Toxicology. 1991;69(1):101–110. [PubMed]
  • Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol. 1996 Apr;16(4):504–510. [PubMed]
  • Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, Kuo TL, Tai TY. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension. 1995 Jan;25(1):53–60. [PubMed]
  • Chen CJ, Kuo TL, Wu MM. Arsenic and cancers. Lancet. 1988 Feb 20;1(8582):414–415. [PubMed]
  • Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988 Sep-Oct;8(5):452–460. [PubMed]
  • Cheng SH, Chiang TL. The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. JAMA. 1997 Jul 9;278(2):89–93. [PubMed]
  • Chiang TL. Taiwan's 1995 health care reform. Health Policy. 1997 Mar;39(3):225–239. [PubMed]
  • Chiou HY, Hsueh YM, Hsieh LL, Hsu LI, Hsu YH, Hsieh FI, Wei ML, Chen HC, Yang HT, Leu LC, et al. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res. 1997 Jun;386(3):197–207. [PubMed]
  • Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997 Sep;28(9):1717–1723. [PubMed]
  • Curcio F, Ceriello A. Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol. 1992 Nov-Dec;28A(11-12):787–790. [PubMed]
  • Del Razo LM, Quintanilla-Vega B, Brambila-Colombres E, Calderón-Aranda ES, Manno M, Albores A. Stress proteins induced by arsenic. Toxicol Appl Pharmacol. 2001 Dec 1;177(2):132–148. [PubMed]
  • Fladeby C, Serck-Hanssen G. Stress-induced glucose uptake in bovine chromaffin cells: a comparison of the effect of arsenite and anisomycin. Biochim Biophys Acta. 1999 Dec 9;1452(3):313–321. [PubMed]
  • Frost SC, Lane MD. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem. 1985 Mar 10;260(5):2646–2652. [PubMed]
  • Gopaul NK, Manraj MD, Hébé A, Lee Kwai Yan S, Johnston A, Carrier MJ, Anggård EE. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia. 2001 Jun;44(6):706–712. [PubMed]
  • Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes. 1987 Apr;36(4):523–534. [PubMed]
  • Henriksen EJ, Holloszy JO. Effects of phenylarsine oxide on stimulation of glucose transport in rat skeletal muscle. Am J Physiol. 1990 Apr;258(4 Pt 1):C648–C653. [PubMed]
  • Hughes MF, Thompson DJ. Subchronic dispositional and toxicological effects of arsenate administered in drinking water to mice. J Toxicol Environ Health. 1996 Oct 11;49(2):177–196. [PubMed]
  • Jhun BH, Hah JS, Jung CY. Phenylarsine oxide causes an insulin-dependent, GLUT4-specific degradation in rat adipocytes. J Biol Chem. 1991 Nov 25;266(33):22260–22265. [PubMed]
  • Kuzuya T. Prevalence of diabetes mellitus in Japan compiled from literature. Diabetes Res Clin Pract. 1994 Oct;24 (Suppl):S15–S21. [PubMed]
  • Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, Wu MM, Tai TY. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol. 1994 Mar 1;139(5):484–492. [PubMed]
  • Liebl B, Mückter H, Doklea E, Fichtl B, Forth W. Influence of 2,3-dimercaptopropanol and other sulfur compounds on oxophenylarsine-mediated inhibition of glucose uptake in MDCK cells. Analyst. 1995 Mar;120(3):771–774. [PubMed]
  • Longnecker MP, Daniels JL. Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect. 2001 Dec;109 (Suppl 6):871–876. [PMC free article] [PubMed]
  • Lorenzi M. Glucose toxicity in the vascular complications of diabetes: the cellular perspective. Diabetes Metab Rev. 1992 Jul;8(2):85–103. [PubMed]
  • Lynn S, Gurr JR, Lai HT, Jan KY. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res. 2000 Mar 17;86(5):514–519. [PubMed]
  • Mahajan SK, Aggarwal HK, Wig N, Maitra S, Chugh SN. Arsenic induced neuropathy. J Assoc Physicians India. 1992 Apr;40(4):268–269. [PubMed]
  • Mitchell RD, Ayala-Fierro F, Carter DE. Systemic indicators of inorganic arsenic toxicity in four animal species. J Toxicol Environ Health A. 2000 Jan 28;59(2):119–134. [PubMed]
  • Morales KH, Ryan L, Kuo TL, Wu MM, Chen CJ. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect. 2000 Jul;108(7):655–661. [PMC free article] [PubMed]
  • Rahman M, Axelson O. Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter. Occup Environ Med. 1995 Nov;52(11):773–774. [PMC free article] [PubMed]
  • Rahman M, Tondel M, Ahmad SA, Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol. 1998 Jul 15;148(2):198–203. [PubMed]
  • Rahman M, Wingren G, Axelson O. Diabetes mellitus among Swedish art glass workers--an effect of arsenic exposure? Scand J Work Environ Health. 1996 Apr;22(2):146–149. [PubMed]
  • Singh RB, Bajaj S, Niaz MA, Rastogi SS, Moshiri M. Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol. 1998 Sep 1;66(1):65–72. [PubMed]
  • Suzuki KT, Tomita T, Ogra Y, Ohmichi M. Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats. Chem Res Toxicol. 2001 Dec;14(12):1604–1611. [PubMed]
  • Tsai SM, Wang TN, Ko YC. Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement. J Toxicol Environ Health A. 1998 Nov 27;55(6):389–404. [PubMed]
  • Tseng CH, Chong CK, Chen CJ, Tai TY. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis. 1996 Feb;120(1-2):125–133. [PubMed]
  • Tseng CH, Tai TY, Chong CK, Tseng CP, Lai MS, Lin BJ, Chiou HY, Hsueh YM, Hsu KH, Chen CJ. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect. 2000 Sep;108(9):847–851. [PMC free article] [PubMed]
  • Wang Chih-Hao, Jeng Jiann-Shing, Yip Ping-Keung, Chen Chi-Ling, Hsu Lin-I, Hsueh Yu-Mei, Chiou Hung-Yi, Wu Meei-Mann, Chen Chien-Jen. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation. 2002 Apr 16;105(15):1804–1809. [PubMed]
  • Wang SL, Pan WH, Hwu CM, Ho LT, Lo CH, Lin SL, Jong YS. Incidence of NIDDM and the effects of gender, obesity and hyperinsulinaemia in Taiwan. Diabetologia. 1997 Dec;40(12):1431–1438. [PubMed]
  • Wu MM, Chiou HY, Wang TW, Hsueh YM, Wang IH, Chen CJ, Lee TC. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ Health Perspect. 2001 Oct;109(10):1011–1017. [PMC free article] [PubMed]
  • Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol. 1989 Dec;130(6):1123–1132. [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...